| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |